1
|
Kieffer C, Primas N, Hutter S, Merckx A, Reininger L, Bach S, Ruchaud S, Gaillard F, Laget M, Amrane D, Hervé L, Castera-Ducros C, Renault J, Dumètre A, Rault S, Doerig C, Rathelot P, Vanelle P, Azas N, Verhaeghe P. Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compound. Bioorg Med Chem 2024; 102:117654. [PMID: 38452406 DOI: 10.1016/j.bmc.2024.117654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 02/22/2024] [Accepted: 02/22/2024] [Indexed: 03/09/2024]
Abstract
We present investigations about the mechanism of action of a previously reported 4-anilino-2-trichloromethylquinazoline antiplasmodial hit-compound (Hit A), which did not share a common mechanism of action with established commercial antimalarials and presented a stage-specific effect on the erythrocytic cycle of P. falciparum at 8 < t < 16 h. The target of Hit A was searched by immobilising the molecule on a solid support via a linker and performing affinity chromatography on a plasmodial lysate. Several anchoring positions of the linker (6,7 and 3') and PEG-type linkers were assessed, to obtain a linked-hit molecule displaying in vitro antiplasmodial activity similar to that of unmodified Hit A. This allowed us to identify the PfPYK-1 kinase and the PfRab6 GTP-ase as potential targets of Hit A.
Collapse
Affiliation(s)
- C Kieffer
- Normandie Univ, UNICAEN, CERMN, 14000 Caen, France
| | - N Primas
- Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; AP-HM, Service Central de la Qualité et de l'Information Pharmaceutiques, Hôpital Conception, Marseille 13005, France
| | - S Hutter
- Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, Marseille, France
| | - A Merckx
- Université Paris Cité, MERIT, IRD, Paris, France
| | - L Reininger
- Sorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, 29680 Roscoff, France; Sorbonne Université, CNRS, FR2424, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique de Roscoff, 29680 Roscoff, France
| | - S Bach
- Sorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, 29680 Roscoff, France; Sorbonne Université, CNRS, FR2424, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique de Roscoff, 29680 Roscoff, France
| | - S Ruchaud
- Sorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, 29680 Roscoff, France; Sorbonne Université, CNRS, FR2424, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique de Roscoff, 29680 Roscoff, France
| | - F Gaillard
- Sorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, 29680 Roscoff, France; Sorbonne Université, CNRS, FR2424, Plateforme de criblage KISSf (Kinase Inhibitor Specialized Screening Facility), Station Biologique de Roscoff, 29680 Roscoff, France
| | - M Laget
- Aix Marseille Univ, INSERMN, SSA, MCT, Marseille, France
| | - D Amrane
- Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France
| | - L Hervé
- Université Paris Cité, MERIT, IRD, Paris, France
| | - C Castera-Ducros
- Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; AP-HM, Service Central de la Qualité et de l'Information Pharmaceutiques, Hôpital Conception, Marseille 13005, France
| | - J Renault
- Université de Rennes - Faculté de Pharmacie, ISCR UMR CNRS 6226, Equipe CORINT, Rennes, France
| | - A Dumètre
- Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, Marseille, France
| | - S Rault
- Normandie Univ, UNICAEN, CERMN, 14000 Caen, France
| | - C Doerig
- School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia
| | - P Rathelot
- Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; AP-HM, Service Central de la Qualité et de l'Information Pharmaceutiques, Hôpital Conception, Marseille 13005, France
| | - P Vanelle
- Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; AP-HM, Service Central de la Qualité et de l'Information Pharmaceutiques, Hôpital Conception, Marseille 13005, France
| | - N Azas
- Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, Marseille, France.
| | - P Verhaeghe
- Univ. Grenoble Alpes, CNRS, DPM UMR 5063, F-38041 Grenoble, France; LCC-CNRS Université de Toulouse, CNRS, UPS, Toulouse, France; Service de Pharmacie, CHU de Nîmes, Place R. Debré, Nîmes, France.
| |
Collapse
|
2
|
Ceramella J, Caruso A, Occhiuzzi MA, Iacopetta D, Barbarossa A, Rizzuti B, Dallemagne P, Rault S, El-Kashef H, Saturnino C, Grande F, Sinicropi MS. Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization. Eur J Med Chem 2019; 181:111583. [DOI: 10.1016/j.ejmech.2019.111583] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2019] [Revised: 07/23/2019] [Accepted: 08/01/2019] [Indexed: 12/26/2022]
|
3
|
Hedir S, De Giorgi M, Fogha J, De Pascale M, Weiswald LB, Brotin E, Marekha B, Denoyelle C, Denis C, Suzanne P, Gautier F, Juin P, Ligat L, Lopez F, Carlier L, Legay R, Bureau R, Rault S, Poulain L, Oliveira Santos JSD, Voisin-Chiret AS. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode. Eur J Med Chem 2018; 159:357-380. [PMID: 30308410 DOI: 10.1016/j.ejmech.2018.10.003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Revised: 09/28/2018] [Accepted: 10/01/2018] [Indexed: 11/18/2022]
Abstract
Protein-protein interactions are attractive targets because they control numerous cellular processes. In oncology, apoptosis regulating Bcl-2 family proteins are of particular interest. Apoptotic cell death is controlled via PPIs between the anti-apoptotic proteins hydrophobic groove and the pro-apoptotic proteins BH3 domain. In ovarian carcinoma, it has been previously demonstrated that Bcl-xL and Mcl-1 cooperate to protect tumor cells against apoptosis. Moreover, Mcl-1 is a key regulator of cancer cell survival and is a known resistance factor to Bcl-2/Bcl-xL pharmacological inhibitors making it an attractive therapeutic target. Here, using a structure-guided design from the oligopyridine lead Pyridoclax based on Noxa/Mcl-1 interaction we identified a new derivative, active at lower concentration as compared to Pyridoclax. This new derivative selectively binds to the Mcl-1 hydrophobic groove and releases Bak and Bim from Mcl-1 to induce cell death and sensitize cancer cells to Bcl-2/Bcl-xL targeting strategies.
Collapse
Affiliation(s)
- Siham Hedir
- Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France
| | - Marcella De Giorgi
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Jade Fogha
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Martina De Pascale
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Louis-Bastien Weiswald
- Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France
| | - Emilie Brotin
- Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France
| | - Bogdan Marekha
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Christophe Denoyelle
- Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France
| | - Camille Denis
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Peggy Suzanne
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Fabien Gautier
- Team 8 "Stress adaptation and tumor escape", CRCINA, UMR 1232 INSERM, Université de Nantes, Université d'Angers, Institut de Recherche en Santé-Université de Nantes, Nantes, France; ICO site René Gauducheau, Boulevard Jacques Monod, Saint Herblain, 44805, France
| | - Philippe Juin
- Team 8 "Stress adaptation and tumor escape", CRCINA, UMR 1232 INSERM, Université de Nantes, Université d'Angers, Institut de Recherche en Santé-Université de Nantes, Nantes, France; ICO site René Gauducheau, Boulevard Jacques Monod, Saint Herblain, 44805, France
| | - Laetitia Ligat
- INSERM UMR1037-Plateforme Protéomique-Pôle Technologique du Centre de Recherches en Cancérologie de Toulouse, 2 avenue Hubert Curien, 31100 Toulouse, France; Université Toulouse III-Paul Sabatier, UMR1037 CRCT, 31000 Toulouse, France
| | - Frédéric Lopez
- INSERM UMR1037-Plateforme Protéomique-Pôle Technologique du Centre de Recherches en Cancérologie de Toulouse, 2 avenue Hubert Curien, 31100 Toulouse, France; Université Toulouse III-Paul Sabatier, UMR1037 CRCT, 31000 Toulouse, France
| | - Ludovic Carlier
- Sorbonne Université, Ecole normale supérieure, PSL University, CNRS, Laboratoire des Biomolécules (LBM), 75005 Paris, France
| | - Rémi Legay
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Ronan Bureau
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Sylvain Rault
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France
| | - Laurent Poulain
- Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE «Interdisciplinary Research Unit for Cancer Prevention and Treatment», Biology and Innovative Therapeutics for Ovarian Cancers Group (BioTICLA), Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France; UNICANCER, Centre de Lutte Contre le Cancer F. Baclesse, 3 avenue du Général Harris, 14076, Caen, France.
| | - Jana Sopková-de Oliveira Santos
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France.
| | - Anne Sophie Voisin-Chiret
- Normandie Univ, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Caen, France.
| |
Collapse
|
4
|
Fogha J, Marekha B, De Giorgi M, Voisin-Chiret AS, Rault S, Bureau R, Sopkova-de Oliveira Santos J. Toward Understanding Mcl-1 Promiscuous and Specific Binding Mode. J Chem Inf Model 2017; 57:2885-2895. [DOI: 10.1021/acs.jcim.7b00396] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Jade Fogha
- Normandie Univ, UNICAEN, CERMN, FR CNRS 3038 INC3M, SF 4206 ICORE bd Becquerel, F-14000 Caen, France
| | - Bogdan Marekha
- Normandie Univ, UNICAEN, CERMN, FR CNRS 3038 INC3M, SF 4206 ICORE bd Becquerel, F-14000 Caen, France
| | - Marcella De Giorgi
- Normandie Univ, UNICAEN, CERMN, FR CNRS 3038 INC3M, SF 4206 ICORE bd Becquerel, F-14000 Caen, France
| | - Anne Sophie Voisin-Chiret
- Normandie Univ, UNICAEN, CERMN, FR CNRS 3038 INC3M, SF 4206 ICORE bd Becquerel, F-14000 Caen, France
| | - Sylvain Rault
- Normandie Univ, UNICAEN, CERMN, FR CNRS 3038 INC3M, SF 4206 ICORE bd Becquerel, F-14000 Caen, France
| | - Ronan Bureau
- Normandie Univ, UNICAEN, CERMN, FR CNRS 3038 INC3M, SF 4206 ICORE bd Becquerel, F-14000 Caen, France
| | | |
Collapse
|
5
|
Kieffer C, Babin V, Jouanne M, Slimani I, Berhault Y, Legay R, Sopková-de Oliveira Santos J, Rault S, Voisin-Chiret AS. Sequential one pot double C H heteroarylation of thiophene using bromopyridines to synthesize unsymmetrical 2,5-bipyridylthiophenes. Tetrahedron 2017. [DOI: 10.1016/j.tet.2017.07.049] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
6
|
Jouanne M, Rault S, Voisin-Chiret AS. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents. Eur J Med Chem 2017; 139:153-167. [PMID: 28800454 DOI: 10.1016/j.ejmech.2017.07.070] [Citation(s) in RCA: 133] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 07/27/2017] [Accepted: 07/28/2017] [Indexed: 12/28/2022]
Abstract
Alzheimer's Disease (AD) is a neurodegenerative brain disorder in which many biological dysfunctions are involved. Among them, two main types of lesions were discovered and widely studied: the amyloid plaques and the neurofibrillary tangles (NFTs). These two lesions are caused by the dysfunction and the accumulation of two proteins which are, respectively, the beta-amyloid peptide and the tau protein. The process that leads these two proteins to aggregate is complex and is the subject of current studies. After a brief description of the aggregation mechanisms, we will provide an overview of new therapeutic agents targeting the different dysfunctions and toxic species found during aggregation.
Collapse
Affiliation(s)
- Marie Jouanne
- Université Caen Normandie, France; UNICAEN, CERMN - EA 4258, FR CNRS 3038 INC3M, SF 4206 ICORE, bd Becquerel, F-14032 Caen, France
| | - Sylvain Rault
- Université Caen Normandie, France; UNICAEN, CERMN - EA 4258, FR CNRS 3038 INC3M, SF 4206 ICORE, bd Becquerel, F-14032 Caen, France
| | - Anne-Sophie Voisin-Chiret
- Université Caen Normandie, France; UNICAEN, CERMN - EA 4258, FR CNRS 3038 INC3M, SF 4206 ICORE, bd Becquerel, F-14032 Caen, France.
| |
Collapse
|
7
|
Jouanne M, Voisin-Chiret AS, Legay R, Coufourier S, Rault S, Sopkova-de Oliveira Santos J. β-Strand Mimicry: Exploring Oligothienylpyridine Foldamers. European J Org Chem 2016. [DOI: 10.1002/ejoc.201600882] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Marie Jouanne
- Université Caen Normandie; Caen France
- UNICAEN; CERMN - EA 4258; FR CNRS 3038 INC3M, SF 4206 ICORE; bd Becquerel 14032 Caen France
| | - Anne Sophie Voisin-Chiret
- Université Caen Normandie; Caen France
- UNICAEN; CERMN - EA 4258; FR CNRS 3038 INC3M, SF 4206 ICORE; bd Becquerel 14032 Caen France
| | - Rémi Legay
- Université Caen Normandie; Caen France
- UNICAEN; CERMN - EA 4258; FR CNRS 3038 INC3M, SF 4206 ICORE; bd Becquerel 14032 Caen France
| | - Sébastien Coufourier
- Université Caen Normandie; Caen France
- UNICAEN; CERMN - EA 4258; FR CNRS 3038 INC3M, SF 4206 ICORE; bd Becquerel 14032 Caen France
| | - Sylvain Rault
- Université Caen Normandie; Caen France
- UNICAEN; CERMN - EA 4258; FR CNRS 3038 INC3M, SF 4206 ICORE; bd Becquerel 14032 Caen France
| | - Jana Sopkova-de Oliveira Santos
- Université Caen Normandie; Caen France
- UNICAEN; CERMN - EA 4258; FR CNRS 3038 INC3M, SF 4206 ICORE; bd Becquerel 14032 Caen France
| |
Collapse
|
8
|
Iacopetta D, Rosano C, Puoci F, Parisi OI, Saturnino C, Caruso A, Longo P, Ceramella J, Malzert-Fréon A, Dallemagne P, Rault S, Sinicropi MS. Multifaceted properties of 1,4-dimethylcarbazoles: Focus on trimethoxybenzamide and trimethoxyphenylurea derivatives as novel human topoisomerase II inhibitors. Eur J Pharm Sci 2016; 96:263-272. [PMID: 27702608 DOI: 10.1016/j.ejps.2016.09.039] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Revised: 09/17/2016] [Accepted: 09/30/2016] [Indexed: 01/17/2023]
Abstract
Natural or synthetic carbazole derivatives have recently attracted the attention of the scientific world because of their multiple biological activity, leading to an increase of designed, synthesized and studied analogues. In this paper, four 1,4-dimethylcarbazole derivatives, analogues of Ellipticine, have been investigated for their ability to block cancer cells growth, with low effects on the proliferation of normal cells. DNA topoisomerases inhibition assays, docking simulations, stability studies and effects on a membrane model are reported. Particularly, compounds 2 and 3 have been found thermally stable and able to inhibit, strongly and selectively, the human DNA topoisomerase II. These properties confer a good and broad antitumoral activity in vitro, with very low cytotoxic effect on the proliferation of normal cell lines and without damaging, in contrast with Ellipticine, the cell membrane model. The presented outcomes set the most active compounds as good candidates for pre-clinical studies useful in cancer treatment.
Collapse
Affiliation(s)
- Domenico Iacopetta
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy
| | - Camillo Rosano
- UOS Proteomics IRCCS AOU San Martino-IST National Institute for Cancer Research, Largo R. Benzi 10, Genoa, Italy
| | - Francesco Puoci
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy
| | - Ortensia Ilaria Parisi
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy
| | - Carmela Saturnino
- Department of Pharmacy, University of Salerno, 84084 Fisciano, Salerno, Italy
| | - Anna Caruso
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy
| | - Pasquale Longo
- Department of Chemistry and Biology, University of Salerno, 84084 Fisciano, Salerno, Italy
| | - Jessica Ceramella
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy
| | - Aurélie Malzert-Fréon
- Normandie Université, UNICAEN, CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie), Caen, France.
| | - Patrick Dallemagne
- Normandie Université, UNICAEN, CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie), Caen, France
| | - Sylvain Rault
- Normandie Université, UNICAEN, CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie), Caen, France
| | - Maria Stefania Sinicropi
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.
| |
Collapse
|
9
|
Guillon J, Dallemagne P, Rault S, Amoros M, Boustie J, Robba M. Synthesis and Anti-HSV-1 Activity of New 3-Amino-3-Arylpropionic Acid Esters. Antivir Chem Chemother 2016. [DOI: 10.1177/095632029600700101] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
A number of 3-methylbut-2-enyl esters of various 3-amino-3-arylpropionic acids have been synthesized and tested for antiviral activity against HSV-1. Many of these compounds, analogues of the 3-methylbut-2-enyl caffeate, isolated from poplar buds, show marked anti-HSV-1 activity and are less toxic than the natural ester.
Collapse
Affiliation(s)
- J. Guillon
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, Laboratoire de Chimie Thérapeutique, U.F.R. des Sciences Pharmaceutiques, 1 rue Vaubénard, 14032 Caen, France
| | - P. Dallemagne
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, Laboratoire de Chimie Thérapeutique, U.F.R. des Sciences Pharmaceutiques, 1 rue Vaubénard, 14032 Caen, France
| | - S. Rault
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, Laboratoire de Chimie Thérapeutique, U.F.R. des Sciences Pharmaceutiques, 1 rue Vaubénard, 14032 Caen, France
| | - M. Amoros
- Laboratoire de Pharmacognosie et de Mycologie, Faculté de Pharmacie, 2 avenue du Professeur Léon-Bernard, 35043 Rennes, France
| | - J. Boustie
- Laboratoire de Pharmacognosie et de Mycologie, Faculté de Pharmacie, 2 avenue du Professeur Léon-Bernard, 35043 Rennes, France
| | - M. Robba
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, Laboratoire de Chimie Thérapeutique, U.F.R. des Sciences Pharmaceutiques, 1 rue Vaubénard, 14032 Caen, France
| |
Collapse
|
10
|
Sinicropi MS, Lappano R, Caruso A, Santolla MF, Pisano A, Rosano C, Capasso A, Panno A, Lancelot JC, Rault S, Saturnino C, Maggiolini M. (6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells. Curr Top Med Chem 2016; 15:1035-42. [PMID: 25786510 DOI: 10.2174/1568026615666150317221549] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2014] [Accepted: 08/23/2014] [Indexed: 11/22/2022]
Abstract
Estrogens control a wide number of aspects of human physiology and play a key role in multiple diseases, including cancer. Estrogens act by binding to and activating the cognate receptor (ER), however numerous studies have revealed that the G protein-coupled receptor named GPR30/GPER mediates also estrogen signals. As ER and GPER share the ability to bind to same compounds, the use of GPER-selective ligands has allowed a better understanding of the biological responses mediated by GPER. In the present study, we designed and synthesized two novel carbazole derivatives and then investigated their ability to interact with and activate the GPER-mediated transduction pathway in breast cancer cells. Both compounds did not activate the classical ER in MCF7 cells, whereas one of the two compounds synthesized triggered through GPER the rapid ERK activation in ER-negative SkBr3 cells, demonstrating a good affinity for GPER in docking studies. The characterization of this novel selective GPER agonist could represent a potential useful tool to provide further insights into the physiopathological role exerted by GPER.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | - Marcello Maggiolini
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende (CS), Italy.
| |
Collapse
|
11
|
Rizza P, Pellegrino M, Caruso A, Iacopetta D, Sinicropi MS, Rault S, Lancelot JC, El-Kashef H, Lesnard A, Rochais C, Dallemagne P, Saturnino C, Giordano F, Catalano S, Andò S. 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression. Eur J Med Chem 2015; 107:275-87. [PMID: 26599533 DOI: 10.1016/j.ejmech.2015.11.004] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2015] [Revised: 10/05/2015] [Accepted: 11/03/2015] [Indexed: 01/01/2023]
Abstract
A series of unknown 3-(alkyl(dialkyl)amino)benzofuro[2,3-f]quinazolin-1(2H)-ones 4-17 has been synthesized as new ellipticine analogs, in which the carbazole moiety and the pyridine ring were replaced by a dibenzofuran residue and a pyrimidine ring, respectively. The synthesis of these benzofuroquinazolinones 4-17 was performed in a simple one-pot reaction using 3-aminodibenzofuran or its 2-methoxy derivative, as starting materials. From 3-(dipropylamino)-5-methoxybenzofuro[2,3-f] quinazolin-1(2H)-one (13), we prepared 3-(dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (18), referred to as DPA-HBFQ-1. The cytotoxic activities of all the synthesized compounds, tested in different human breast cancer cell lines, revealed that DPA-HBFQ-1 was the most active compound. In particular, the latter was able to inhibit anchorage-dependent and -independent cell growth and to induce apoptosis in estrogen receptor alpha (ERα)-positive and -negative breast cancer cells. It did not affect proliferation and apoptotic responses in MCF-10A normal breast epithelial cells. The observed effects have been ascribed to an enhanced p21(Cip1/WAF1) expression in a p53-dependent manner of tumor suppressor and to a selective inhibition of human topoisomerase II. In addition, DPA-HBFQ-1 exerted growth inhibitory effects also in other cancer cell lines, even though with a lower cytotoxic activity. Our results indicate DPA-HBFQ-1 as a good candidate to be useful as cancer therapeutic agent, particularly for breast cancer.
Collapse
Affiliation(s)
- Pietro Rizza
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy
| | - Michele Pellegrino
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy
| | - Anna Caruso
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy
| | - Domenico Iacopetta
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy
| | - Maria Stefania Sinicropi
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy.
| | - Sylvain Rault
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258, FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France.
| | - Jean Charles Lancelot
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258, FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Hussein El-Kashef
- Department of Chemistry, Faculty of Science, Assiut University, 71516 Assiut, Egypt
| | - Aurelien Lesnard
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258, FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Christophe Rochais
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258, FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Patrick Dallemagne
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258, FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Carmela Saturnino
- Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Salerno, Italy
| | - Francesca Giordano
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy
| | - Stefania Catalano
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy
| | - Sebastiano Andò
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy.
| |
Collapse
|
12
|
Kieffer C, Cohen A, Verhaeghe P, Paloque L, Hutter S, Castera-Ducros C, Laget M, Rault S, Valentin A, Rathelot P, Azas N, Vanelle P. Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series. Bioorg Med Chem 2015; 23:2377-86. [DOI: 10.1016/j.bmc.2015.03.064] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2015] [Revised: 03/23/2015] [Accepted: 03/24/2015] [Indexed: 10/23/2022]
|
13
|
Fontaine F, Héquet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: Study of 6-substituted pyridine-3-boronic acid derivatives. Eur J Med Chem 2015; 95:185-98. [DOI: 10.1016/j.ejmech.2015.02.056] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Revised: 02/26/2015] [Accepted: 02/28/2015] [Indexed: 02/06/2023]
|
14
|
Cohen A, Suzanne P, Lancelot JC, Verhaeghe P, Lesnard A, Basmaciyan L, Hutter S, Laget M, Dumètre A, Paloque L, Deharo E, Crozet MD, Rathelot P, Dallemagne P, Lorthiois A, Sibley CH, Vanelle P, Valentin A, Mazier D, Rault S, Azas N. Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium. Eur J Med Chem 2015; 95:16-28. [DOI: 10.1016/j.ejmech.2015.03.011] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2014] [Revised: 03/03/2015] [Accepted: 03/04/2015] [Indexed: 11/24/2022]
|
15
|
Kieffer C, Cohen A, Verhaeghe P, Hutter S, Castera-Ducros C, Laget M, Remusat V, M'Rabet MK, Rault S, Rathelot P, Azas N, Vanelle P. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series. Eur J Med Chem 2015; 92:282-94. [DOI: 10.1016/j.ejmech.2014.12.056] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2014] [Revised: 12/03/2014] [Accepted: 12/30/2014] [Indexed: 12/31/2022]
|
16
|
Gloaguen C, Voisin-Chiret AS, Sopkova-de Oliveira Santos J, Fogha J, Gautier F, De Giorgi M, Burzicki G, Perato S, Pétigny-Lechartier C, Simonin-Le Jeune K, Brotin E, Goux D, N'Diaye M, Lambert B, Louis MH, Ligat L, Lopez F, Juin P, Bureau R, Rault S, Poulain L. First evidence that oligopyridines, α-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies. J Med Chem 2015; 58:1644-68. [PMID: 25585174 DOI: 10.1021/jm500672y] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Apoptosis control defects such as the deregulation of Bcl-2 family member expression are frequently involved in chemoresistance. In ovarian carcinoma, we previously demonstrated that Bcl-xL and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy. Whereas Bcl-xL inhibitors are now available, Mcl-1 inhibition, required to sensitize cells to Bcl-xL-targeting strategies, remains problematic. In this context, we designed and synthesized oligopyridines potentially targeting the Mcl-1 hydrophobic pocket, evaluated their capacity to inhibit Mcl-1 in live cells, and implemented a functional screening assay to evaluate their ability to sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies. We established structure-activity relationships and focused our attention on MR29072, named Pyridoclax. Surface plasmon resonance assay demonstrated that pyridoclax directly binds to Mcl-1. Without cytotoxic activity when administered as a single agent, pyridoclax induced apoptosis in combination with Bcl-xL-targeting siRNA or with ABT-737 in ovarian, lung, and mesothelioma cancer cells.
Collapse
|
17
|
Hamdi A, Lesnard A, Suzanne P, Robert T, Miteva MA, Pellerano M, Didier B, Ficko-Blean E, Lobstein A, Hibert M, Rault S, Morris MC, Colas P. Tampering with Cell Division by Using Small-Molecule Inhibitors of CDK-CKS Protein Interactions. Chembiochem 2015; 16:432-9. [DOI: 10.1002/cbic.201402579] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2014] [Indexed: 11/07/2022]
|
18
|
Dumas N, Moulin-Sallanon M, Ginovart N, Tournier BB, Suzanne P, Cailly T, Fabis F, Rault S, Charnay Y, Millet P. Small-animal single-photon emission computed tomographic imaging of the brain serotoninergic systems in wild-type and mdr1a knockout rats. Mol Imaging 2014; 13. [PMID: 24622810 DOI: 10.2310/7290.2013.00072] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
The pharmacokinetic properties of radiotracers are crucial for successful in vivo single-photon emission computed tomographic (SPECT) imaging. Our goal was to determine if MDR1A-deficient animals could allow better SPECT imaging outcomes than wild-type (WT) animals for a selection of serotoninergic radioligands. Thus, we compared the performances of 123I-p-MPPI, 123I-R91150, 123I-SB207710, and 123I-ADAM radioligands, for imaging of their respective targets (5-hydroxytryptamine [5-HT]1A, 5-HT2A, 5-HT4, and serotonin transporter [SERT]), in WT and Mdr1a knockout (KO) rats. With 123I-SB207710, virtually no SPECT signal was recorded in the brain of WT or KO animals. For 123I-p-MPPI, low nondisplaceable binding potentials (BPND, mean ± SD) were observed in WT (0.49 ± 0.25) and KO (0.89 ± 0.52) animals. For 123I-ADAM, modest imaging contrast was observed in WT (1.27 ± 0.02) and KO (1.31 ± 0.09) animals. For 123I-R91150, the BPND were significantly higher in Mdr1a KO (3.98 ± 0.65) animals compared to WT animals (1.22 ± 0.26). The pharmacokinetics of 123I-SB207710 and 123I-p-MPPI do not make them ideal tracers for preclinical SPECT neuroimaging. 123I-ADAM showed adequate brain uptake regardless of Mdr1a expression and appeared suitable for preclinical SPECT neuroimaging in both animal strains. The use of Mdr1a KO animals significantly improved the brain penetration of 123I-R91150, making this animal strain an interesting option when considering SPECT neuroimaging of 5-HT2A receptors in rat.
Collapse
|
19
|
Neveu C, Dulin F, Lefranc B, Galas L, Calbrix C, Bureau R, Rault S, Chuquet J, Boutin JA, Guilhaudis L, Ségalas-Milazzo I, Vaudry D, Vaudry H, Santos JSDO, Leprince J. Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. Br J Pharmacol 2014; 171:4425-39. [PMID: 24913445 DOI: 10.1111/bph.12808] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2013] [Revised: 04/04/2014] [Accepted: 05/15/2014] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND AND PURPOSE The neuropeptide 26RFa and its cognate receptor GPR103 are involved in the control of food intake and bone mineralization. Here, we have tested, experimentally, the predicted ligand-receptor interactions by site-directed mutagenesis of GPR103 and designed point-substituted 26RFa analogues. EXPERIMENTAL APPROACH Using the X-ray structure of the β2 -adrenoceptor, a 3-D molecular model of GPR103 has been built. The bioactive C-terminal octapeptide 26RFa(19-26) , KGGFSFRF-NH2 , was docked in this GPR103 model and the ligand-receptor complex was submitted to energy minimization. KEY RESULTS In the most stable complex, the Phe-Arg-Phe-NH2 part was oriented inside the receptor cavity, whereas the N-terminal Lys residue remained outside. A strong intermolecular interaction was predicted between the Arg(25) residue of 26RFa and the Gln(125) residue located in the third transmembrane helix of GPR103. To confirm this interaction experimentally, we tested the ability of 26RFa and Arg-modified 26RFa analogues to activate the wild-type and the Q125A mutant receptors transiently expressed in CHO cells. 26RFa (10(-6) M) enhanced [Ca(2+) ]i in wild-type GPR103-transfected cells, but failed to increase [Ca(2+) ]i in Q125A mutant receptor-expressing cells. Moreover, asymmetric dimethylation of the side chain of arginine led to a 26RFa analogue, [ADMA(25) ]26RFa(20-26) , that was unable to activate the wild-type GPR103, but antagonized 26RFa-evoked [Ca(2+) ]i increase. CONCLUSION AND IMPLICATIONS Altogether, these data provide strong evidence for a functional interaction between the Arg(25) residue of 26RFa and the Gln(125) residue of GPR103 upon ligand-receptor activation, which can be exploited for the rational design of potent GPR103 agonists and antagonists.
Collapse
Affiliation(s)
- C Neveu
- Inserm U982, Laboratory of Neuronal and Neuroendocrine Cell Differentiation and Communication, Neurotrophic Factors and Neuronal Differentiation Team, Institute for Research and Innovation in Biomedicine (IRIB); Cell Imaging Platform of Normandy (PRIMACEN), IRIB; Normandie Univ, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Primas N, Suzanne P, Verhaeghe P, Hutter S, Kieffer C, Laget M, Cohen A, Broggi J, Lancelot JC, Lesnard A, Dallemagne P, Rathelot P, Rault S, Vanelle P, Azas N. Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents. Eur J Med Chem 2014; 83:26-35. [DOI: 10.1016/j.ejmech.2014.06.014] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2014] [Revised: 05/26/2014] [Accepted: 06/08/2014] [Indexed: 10/25/2022]
|
21
|
Lepailleur A, Freret T, Lemaître S, Boulouard M, Dauphin F, Hinschberger A, Dulin F, Lesnard A, Bureau R, Rault S. Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology. J Chem Inf Model 2014; 54:1773-84. [PMID: 24857631 DOI: 10.1021/ci500157n] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
In recent years, preclinical and clinical studies have generated considerable interest in the development of histamine H3 receptor (H3R) antagonists as novel treatment for degenerative disorders associated with impaired cholinergic function. To identify novel scaffolds for H3R antagonism, a common feature-based pharmacophore model was developed and used to screen the 17,194 compounds of the CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) chemical library. Out of 268 virtual hits which have been gathered in 34 clusters, we were particularly interested in tricyclic derivatives also exhibiting a potent 5HT4R affinity. Benzo[h][1,6]naphthyridine derivatives showed the highest H3R affinity, and compound 17 (H3R Ki = 41.6 nM; 5-HT4R Ki = 208 nM) completely reversed the amnesiant effect of scopolamine at 3 mg/kg in a spatial working memory experiment. For the first time we demonstrated the feasibility to combine H3R and 5-HT4R activities in a single molecule, raising the exciting possibility that dual H3R antagonist/5HT4R agonist have potential for the treatment of neurodegenerative diseases such as Alzheimer's disease.
Collapse
|
22
|
Perato S, Giorgi M, Burzicki G, Legalite F, Rault S, Voisin-Chiret A. Focus on Microwaves Assisted Halogen-halogen Exchange Reaction Conditions on 2-Halopyridines. CMIC 2014. [DOI: 10.2174/22133356114019990003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
23
|
Panno A, Sinicropi MS, Caruso A, El-Kashef H, Lancelot JC, Aubert G, Lesnard A, Cresteil T, Rault S. New Trimethoxybenzamides and Trimethoxyphenylureas Derived from Dimethylcarbazole as Cytotoxic Agents. Part I. J Heterocycl Chem 2014. [DOI: 10.1002/jhet.1951] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Antonella Panno
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M, Bd Becquerel; 14032 Caen Cedex France
- Dipartimento di Scienze Farmaceutiche; Università della Calabria; 87036 Arcavacata di Rende Cosenza Italy
| | - Maria Stefania Sinicropi
- Dipartimento di Scienze Farmaceutiche; Università della Calabria; 87036 Arcavacata di Rende Cosenza Italy
| | - Anna Caruso
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M, Bd Becquerel; 14032 Caen Cedex France
- Dipartimento di Scienze Farmaceutiche; Università della Calabria; 87036 Arcavacata di Rende Cosenza Italy
| | - Hussein El-Kashef
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M, Bd Becquerel; 14032 Caen Cedex France
- Chemistry Department, Faculty of Science; Assiut University; 71516 Assiut Egypt
| | - Jean-Charles Lancelot
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M, Bd Becquerel; 14032 Caen Cedex France
| | - Geneviève Aubert
- Institut de Chimie des Substances Naturelles, UPR 2301; CNRS; Avenue de la Terrasse 91198 Gif-sur-Yvette France
| | - Aurélien Lesnard
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M, Bd Becquerel; 14032 Caen Cedex France
| | - Thierry Cresteil
- Institut de Chimie des Substances Naturelles, UPR 2301; CNRS; Avenue de la Terrasse 91198 Gif-sur-Yvette France
| | - Sylvain Rault
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M, Bd Becquerel; 14032 Caen Cedex France
| |
Collapse
|
24
|
Caruso A, Lancelot JC, El-Kashef H, Panno A, Sinicropi MS, Legay R, Lesnard A, Lepailleur A, Rault S. Four Partners, Three-Step, One-Pot Reaction for a Library of New 2-Alkyl(dialkyl)aminoquinazolin-4(3H)-ones. J Heterocycl Chem 2014. [DOI: 10.1002/jhet.1942] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Anna Caruso
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
- Dipartimento di Farmacia e Scienze della Salute e della Nutrizione; Università della Calabria; 87036 Arcavacata di Rende Cosenza Italy
| | - Jean-Charles Lancelot
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
| | - Hussein El-Kashef
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
- Chemistry Department, Faculty of Science; Assiut University; 71516 Assiut Egypt
| | - Antonella Panno
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
- Dipartimento di Farmacia e Scienze della Salute e della Nutrizione; Università della Calabria; 87036 Arcavacata di Rende Cosenza Italy
| | - Maria Stefania Sinicropi
- Dipartimento di Farmacia e Scienze della Salute e della Nutrizione; Università della Calabria; 87036 Arcavacata di Rende Cosenza Italy
| | - Rémi Legay
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
| | - Aurélien Lesnard
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
| | - Alban Lepailleur
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
| | - Sylvain Rault
- Université de Caen Basse-Normandie; Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M; Bd Becquerel 14032 Caen Cedex France
| |
Collapse
|
25
|
Fontaine F, Hequet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S. First Identification of Boronic Species as Novel Potential Inhibitors of the Staphylococcus aureus NorA Efflux Pump. J Med Chem 2014; 57:2536-48. [DOI: 10.1021/jm401808n] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Fanny Fontaine
- Normandie Univ, France
- UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie) − FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France
| | - Arnaud Hequet
- Chimie ParisTech (Ecole Nationale Supérieure de Chimie de Paris), Laboratoire Charles Friedel, UMR-7223, CNRS, 11 rue Pierre et Marie Curie, F-75231 Paris Cedex 05, France
| | - Anne-Sophie Voisin-Chiret
- Normandie Univ, France
- UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie) − FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France
| | - Alexandre Bouillon
- BoroChem S.A.S., 10 rue du Professeur
Zarifian, F-14200 Hérouville Saint Clair, France
| | - Aurélien Lesnard
- Normandie Univ, France
- UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie) − FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France
| | - Thierry Cresteil
- Institut de Chimie des Substances Naturelles, CNRS, UPR 2301, avenue de la Terrasse, F-91198 Gif sur Yvette, France
| | - Claude Jolivalt
- Chimie ParisTech (Ecole Nationale Supérieure de Chimie de Paris), Laboratoire Charles Friedel, UMR-7223, CNRS, 11 rue Pierre et Marie Curie, F-75231 Paris Cedex 05, France
| | - Sylvain Rault
- Normandie Univ, France
- UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie) − FR CNRS INC3M, Boulevard Becquerel, 14032 Caen, France
| |
Collapse
|
26
|
Caruso A, Sinicropi MS, Lancelot JC, El-Kashef H, Saturnino C, Aubert G, Ballandonne C, Lesnard A, Cresteil T, Dallemagne P, Rault S. Synthesis and evaluation of cytotoxic activities of new guanidines derived from carbazoles. Bioorg Med Chem Lett 2013; 24:467-72. [PMID: 24374274 DOI: 10.1016/j.bmcl.2013.12.047] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2013] [Revised: 12/10/2013] [Accepted: 12/11/2013] [Indexed: 10/25/2022]
Abstract
Several new alkylguanidines derived from carbazole have been synthesized in a simple one-pot reaction starting from 3-aminocarbazole derivatives. The aminocarbazoles were reacted with ethoxycarbonylisothiocyanate, to give thiourea intermediates, followed by the addition of an alkylamine and HgCl2 to give ethoxycarbonylguanidine intermediates. The reaction mixture was then heated at 160 °C to give the N-(1,4-dimethyl-9H-carbazol-3-yl)-N'-alkylguanidines. The cytotoxic activity of all the synthesized guanidines was evaluated against different cell lines.
Collapse
Affiliation(s)
- Anna Caruso
- Department of Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Arcavacata di Rende, Cosenza, Italy; Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Maria Stefania Sinicropi
- Department of Pharmacy, Health and Nutrition Sciences, University of Calabria, 87036 Arcavacata di Rende, Cosenza, Italy.
| | - Jean-Charles Lancelot
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Hussein El-Kashef
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France; Chemistry Department, Faculty of Science, Assiut University, 71516 Assiut, Egypt
| | - Carmela Saturnino
- Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Salerno, Italy
| | - Geneviève Aubert
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, Avenue de la Terrasse, 91198 Gif-sur-Yvette, France
| | - Céline Ballandonne
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Aurélien Lesnard
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Thierry Cresteil
- Institut de Chimie des Substances Naturelles, UPR 2301, CNRS, Avenue de la Terrasse, 91198 Gif-sur-Yvette, France
| | - Patrick Dallemagne
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| | - Sylvain Rault
- Université de Caen Basse-Normandie, Centre d'Etudes et de Recherche sur le Médicament de Normandie UPRES EA 4258 - FR CNRS 3038 INC3M, Bd Becquerel, 14032 Caen Cedex, France
| |
Collapse
|
27
|
Brossard D, Zhang Y, Haider SM, Sgobba M, Khalid M, Legay R, Duterque-Coquillaud M, Galera P, Rault S, Dallemagne P, Moslemi S, El Kihel L. N-substituted Piperazinopyridylsteroid Derivatives as Abiraterone Analogues Inhibit Growth and Induce Pro-apoptosis in Human Hormone-independent Prostate Cancer Cell Lines. Chem Biol Drug Des 2013; 82:620-9. [DOI: 10.1111/cbdd.12195] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2012] [Revised: 06/07/2013] [Accepted: 07/11/2013] [Indexed: 02/01/2023]
Affiliation(s)
| | | | - Shozeb M. Haider
- Centre for Cancer Research and Cell Biology; Queen's University Belfast; 97 Lisburn Road; Belfast; BT9 7BL; UK
| | - Miriam Sgobba
- Centre for Cancer Research and Cell Biology; Queen's University Belfast; 97 Lisburn Road; Belfast; BT9 7BL; UK
| | - Mohamed Khalid
- Faculté des Sciences et Techniques; Université Hassan Premier; Km 3, Route de Casablanca, BP 577; 26000; Settat; Morocco
| | | | - Martine Duterque-Coquillaud
- Institut Pasteur de Lille/IFR142; CNRS UMR 8161; Institut de Biologie de Lille; Université de Lille Nord; 1 rue du Professeur Calmette, B.P.447; 59021; Lille cedex; France
| | | | | | | | | | | |
Collapse
|
28
|
Perato S, Fogha J, Sebban M, Voisin-Chiret AS, Sopkova-de Oliveira Santos J, Oulyadi H, Rault S. Conformation Control of Abiotic α-Helical Foldamers. J Chem Inf Model 2013; 53:2671-80. [DOI: 10.1021/ci400365y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Serge Perato
- Normandie Université, France
- UNICAEN, CERMN (Centre d’Etudes
et de Recherche sur
le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M,
Bd Becquerel), F-14032 Caen, France
| | - Jade Fogha
- Normandie Université, France
- UNICAEN, CERMN (Centre d’Etudes
et de Recherche sur
le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M,
Bd Becquerel), F-14032 Caen, France
| | - Muriel Sebban
- Université de Rouen, COBRA-UMR 6014, Rue Lucien
Tesnières, F-76821 Mont-Saint-Aignan, France
| | - Anne Sophie Voisin-Chiret
- Normandie Université, France
- UNICAEN, CERMN (Centre d’Etudes
et de Recherche sur
le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M,
Bd Becquerel), F-14032 Caen, France
| | - Jana Sopkova-de Oliveira Santos
- Normandie Université, France
- UNICAEN, CERMN (Centre d’Etudes
et de Recherche sur
le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M,
Bd Becquerel), F-14032 Caen, France
| | - Hassan Oulyadi
- Université de Rouen, COBRA-UMR 6014, Rue Lucien
Tesnières, F-76821 Mont-Saint-Aignan, France
| | - Sylvain Rault
- Normandie Université, France
- UNICAEN, CERMN (Centre d’Etudes
et de Recherche sur
le Médicament de Normandie UPRES EA 4258-FR CNRS 3038 INC3M,
Bd Becquerel), F-14032 Caen, France
| |
Collapse
|
29
|
Tomasina J, Poulain L, Abeilard E, Giffard F, Brotin E, Carduner L, Carreiras F, Gauduchon P, Rault S, Malzert-Fréon A. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma. Int J Pharm 2013; 458:197-207. [PMID: 24084450 DOI: 10.1016/j.ijpharm.2013.09.025] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2013] [Revised: 09/20/2013] [Accepted: 09/22/2013] [Indexed: 01/22/2023]
Abstract
We report the development of folate-functionalized nanoparticles able to target folate receptors, and to deliver a poorly water soluble cytotoxic agent, a tripentone, in ovarian carcinoma. The stability under incubation of lipid nanoparticles formulated by a low-energy phase inversion temperature method was investigated. Thanks to the presence of Labrasol(®), a macrogolglyceride into the composition of the nanocarriers, the conjugation of different quantities of a folate derivate (folic acid-polyethylene glycol2000-distearylphosphatidylethanolamine) to nanoparticles was possible by a rapid, soft, very simple post-insertion process. As determined by dynamic light scattering, nanoparticles present a monodisperse diameter of about 100 nm, a spherical shape as attested by transmission electron micrographs, a weakly negative surface zeta potential, and are able to encapsulate the tripentone MR22388. The presence of folate receptors on SKOV3 human ovarian cancer cells was identified by fluorescent immunocytochemistry. Cellular uptake studies assessed by flow cytometry indicated that these nanoparticles reached the SKOV3 cells rapidly, and were internalized by a folate-receptor mediated endocytosis pathway. Moreover, nanoparticles allowed the rapid delivery of the antitumor agent tripentone into cells as shown in vitro by real-time cellular activity assay. Such folate-lipid nanoparticles are a potential carrier for targeted delivery of poorly water soluble compounds into ovarian carcinoma.
Collapse
Affiliation(s)
- J Tomasina
- Normandie Univ, France; UNICAEN, CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie - FR CNRS INC3M - SF ICORE, Université de Caen Basse-Normandie, UFR des Sciences Pharmaceutiques Bd Becquerel), F-14032 Caen, France; UNICAEN, BioTICLA (Centre de Lutte Contre le Cancer F Baclesse, SF ICORE, Université de Caen Basse-Normandie, UFR des Sciences Pharmaceutiques Bd Becquerel), F-14032 Caen, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
De Giorgi M, Voisin-Chiret A, Rault S. Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues. Curr Med Chem 2013; 20:2964-78. [DOI: 10.2174/0929867311320240003] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2013] [Accepted: 05/29/2013] [Indexed: 11/22/2022]
|
31
|
Tomasina J, Malzert-Freon A, Giffard F, Brotin E, Louis MH, Abeilard E, Rault S, Gauduchon P, Poulain L. Sensitization of ovarian carcinoma cells to Bcl-xL-targeting strategies through indirect modulation of Mcl-1 activity by MR22388, a molecule of the tripentone family. J Ovarian Res 2013; 6:38. [PMID: 23735052 PMCID: PMC3700836 DOI: 10.1186/1757-2215-6-38] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2013] [Accepted: 05/25/2013] [Indexed: 12/29/2022] Open
Abstract
Background Our work has been carried out in the context of the therapeutic failure in ovarian carcinoma, which remains the leading cause of death by gynecologic malignancy. In these tumours, recurrence and subsequent acquired chemoresistance constitute major hurdles to successful therapy. Here we studied the interest of a member of the tripentone chemical family, MR22388, for the treatment of chemoresistant ovarian cancer cells. Findings MR22388 activity has been assessed in vitro on cisplatin-resistant (SKOV3 and IGROV1-R10) ovarian cancer cell lines by conventional analysis, alone or combined to a BH3-mimetic molecule, ABT-737. MR22388 exerts its activity on cisplatin resistant cells, and we showed that it induces a decrease of the Mcl-1 anti-apoptotic protein expression. Considering our previous work demonstrating that the efficiency of Bcl-xL targeting strategies is conditioned to the concomitant inhibition of Mcl-1 we studied the interest of the association of this MR22388 with ABT-737, and showed that this combination was highly cytotoxic in chemoresistant cells. Conclusions This work thus opens new perspectives for the use of this promising molecule for the treatment of highly chemoresistant ovarian cancer cells and for sensitization of emerging Bcl-xL targeting strategies such as the use of BH3-mimetic molecules.
Collapse
|
32
|
Tomasina J, Lheureux S, Gauduchon P, Rault S, Malzert-Fréon A. Nanocarriers for the targeted treatment of ovarian cancers. Biomaterials 2013; 34:1073-101. [DOI: 10.1016/j.biomaterials.2012.10.055] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2012] [Accepted: 10/23/2012] [Indexed: 12/09/2022]
|
33
|
Rochais C, Cresteil T, Perri V, Jouanne M, Lesnard A, Rault S, Dallemagne P. MR22388, a novel anti-cancer agent with a strong FLT-3 ITD kinase affinity. Cancer Lett 2012; 331:92-8. [PMID: 23268332 DOI: 10.1016/j.canlet.2012.12.017] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2012] [Revised: 12/03/2012] [Accepted: 12/09/2012] [Indexed: 11/26/2022]
Abstract
This work describes the study of the mechanism of action and spectrum of activity of MR22388, a novel anti-cancer agent belonging to the tripentone series. MR22388 is highly cytotoxic (within the nanomolar range) against numerous cancer cell lines and studies of its cytotoxicity mechanisms show that it is a weak inhibitor of the polymerization of tubulin and that it induces apoptosis via the MAP kinase pathways. Further MR22388 is a very strong inhibitor of several kinases including the tyrosine kinase FLT3-ITD. FLT3-ITD is a mutated form of the tyrosine kinase receptor (RTK) FLT3, resulting in the constitutive activation of the kinase, occurring in about 25% of normal karyotypes' Acute Myeloid Leukemia (AML) and is linked to a bad prognosis. Consecutively, MR22388 appears as a novel promising anticancer lead agent especially for AML therapy.
Collapse
Affiliation(s)
- Christophe Rochais
- CERMN, UFR des Sciences Pharmaceutiques, UPRES EA 4258 - FR CNRS 3038 INC3M - SF 4206 ICORE, Université de Caen Basse-Normandie, Bd Becquerel, 14032 Caen cedex, France.
| | | | | | | | | | | | | |
Collapse
|
34
|
Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F. Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers. J Med Chem 2012; 55:9693-707. [PMID: 23102207 DOI: 10.1021/jm300943r] [Citation(s) in RCA: 74] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The work described herein aims at finding new potential ligands for the brain imaging of 5-HT(4) receptors (5-HT(4)Rs) using single-photon emission computed tomography (SPECT). Starting from the nonsubstituted phenanthridine compound 4a, exhibiting a K(i) value of 51 nM on the 5-HT(4)R, we explored the structure-affinity in this series. We found that substitution in position 4 of the tricycle with a fluorine atom gave the best result. Introduction of an additional nitrogen atom inside the tricyclic framework led to an increase of both the affinity and selectivity for 5-HT(4)R, suggesting the design of the antagonist 4v, exhibiting a high affinity of 0.04 nM. Several iodinated analogues were then synthesized as potential SPECT tracers. The iodinated compound 11d was able to displace the reference radioiodinated 5-HT(4)R antagonist (1-butylpiperidin-4-yl)methyl-8-amino-7-iodo[(123)I]-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate {[(123)I]1, [(123)I]SB 207710} both in vitro and in vivo in brain. Compound 11d was radiolabeled with [(125)I]iodine, providing a potential SPECT candidate for brain imaging of 5-HT(4)R.
Collapse
Affiliation(s)
- Emmanuelle Dubost
- UFR des Sciences Pharmaceutiques, Université de Caen Basse-Normandie, EA 4258 CERMN, FR CNRS 3038 INC3M, SF-4206 ICORE, Boulevard Becquerel, F-14032 Caen, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Szalata C, Szymoniak J, Fabis F, Butt-Gueulle S, Rault S, Bertus P, Gérard S, Sapi J. Cyclopropyl-tryptamine analogues: synthesis and biological evaluation as 5-HT(6) receptor ligands. ChemMedChem 2012; 8:70-3. [PMID: 23129513 DOI: 10.1002/cmdc.201200396] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2012] [Indexed: 11/06/2022]
Abstract
Conformational restrictions: Based on the pharmacophore model for 5-HT(6) receptor ligands (shown), tryptamine analogues bearing a cyclopropyl ring on the α-position of the tryptamine side chain were synthesized and evaluated against 5-HT receptors. N,N-Dimethyl-1-arylsulfonyltryptamine derivatives exhibited promising selectivity for 5-HT(6) over 5-HT(1a) and 5-HT(4) receptors and interesting activity against 5-HT(6) (K(i) =∼0.15 μM; IC(50) =∼0.20 μM).
Collapse
Affiliation(s)
- Claude Szalata
- Institut de Chimie Moléculaire de Reims, UMR CNRS 7312 (ex 6229), Faculté de Pharmacie, Université de Reims-Champagne-Ardenne, 51096 Reims Cedex and UFR Sciences, 51687, Reims Cedex 2, France
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Lohou E, Sopkova-de Oliveira Santos J, Schumann-Bard P, Boulouard M, Stiebing S, Rault S, Collot V. New hypotheses for the binding mode of 4- and 7-substituted indazoles in the active site of neuronal nitric oxide synthase. Bioorg Med Chem 2012; 20:5296-304. [DOI: 10.1016/j.bmc.2012.06.025] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2012] [Revised: 06/11/2012] [Accepted: 06/13/2012] [Indexed: 02/06/2023]
|
37
|
Primas N, Verhaeghe P, Cohen A, Kieffer C, Dumètre A, Hutter S, Rault S, Rathelot P, Azas N, Vanelle P. A new synthetic route to original sulfonamide derivatives in 2-trichloromethylquinazoline series: a structure-activity relationship study of antiplasmodial activity. Molecules 2012; 17:8105-17. [PMID: 22766802 PMCID: PMC6269066 DOI: 10.3390/molecules17078105] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2012] [Revised: 06/25/2012] [Accepted: 06/26/2012] [Indexed: 01/14/2023] Open
Abstract
We report herein a simple and efficient two-step synthetic approach to new 2-trichloromethylquinazolines possessing a variously substituted sulfonamide group at position 4 used to prepare new quinazolines with antiparasitic properties. Thus, an original series of 20 derivatives was synthesized, which proved to be less-toxic than previously synthesized hits on the human HepG2 cell line, but did not display significant antiplasmodial activity. A brief Structure-Activity Relationship (SAR) evaluation shows that a more restricted conformational freedom is probably necessary for providing antiplasmodial activity.
Collapse
Affiliation(s)
- Nicolas Primas
- Laboratoire de Pharmacochimie Radicalaire, Faculté de Pharmacie, Institut de Chimie Radicalaire UMR CNRS 7273, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille cedex 05, France; (N.P.); (P.V.); (A.C.); (C.K.); (P.R.)
| | - Pierre Verhaeghe
- Laboratoire de Pharmacochimie Radicalaire, Faculté de Pharmacie, Institut de Chimie Radicalaire UMR CNRS 7273, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille cedex 05, France; (N.P.); (P.V.); (A.C.); (C.K.); (P.R.)
| | - Anita Cohen
- Laboratoire de Pharmacochimie Radicalaire, Faculté de Pharmacie, Institut de Chimie Radicalaire UMR CNRS 7273, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille cedex 05, France; (N.P.); (P.V.); (A.C.); (C.K.); (P.R.)
- Infections Parasitaires, Transmission, Physiopathologie et Thérapeutique, UMR MD3, Faculté de Pharmacie, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France; (A.D.); (S.H.); (N.A.)
| | - Charline Kieffer
- Laboratoire de Pharmacochimie Radicalaire, Faculté de Pharmacie, Institut de Chimie Radicalaire UMR CNRS 7273, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille cedex 05, France; (N.P.); (P.V.); (A.C.); (C.K.); (P.R.)
| | - Aurélien Dumètre
- Infections Parasitaires, Transmission, Physiopathologie et Thérapeutique, UMR MD3, Faculté de Pharmacie, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France; (A.D.); (S.H.); (N.A.)
| | - Sébastien Hutter
- Infections Parasitaires, Transmission, Physiopathologie et Thérapeutique, UMR MD3, Faculté de Pharmacie, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France; (A.D.); (S.H.); (N.A.)
| | - Sylvain Rault
- Centre d’Etudes et de Recherche sur le Médicament de Normandie, UPRES EA 4258, FR CNRS 3038 INC3M, UFR des Sciences Pharmaceutiques, Université de Caen Basse-Normandie, Boulevard Becquerel, 14032 Caen Cedex, France;
| | - Pascal Rathelot
- Laboratoire de Pharmacochimie Radicalaire, Faculté de Pharmacie, Institut de Chimie Radicalaire UMR CNRS 7273, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille cedex 05, France; (N.P.); (P.V.); (A.C.); (C.K.); (P.R.)
| | - Nadine Azas
- Infections Parasitaires, Transmission, Physiopathologie et Thérapeutique, UMR MD3, Faculté de Pharmacie, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France; (A.D.); (S.H.); (N.A.)
| | - Patrice Vanelle
- Laboratoire de Pharmacochimie Radicalaire, Faculté de Pharmacie, Institut de Chimie Radicalaire UMR CNRS 7273, Aix-Marseille Univ, 27 Boulevard Jean Moulin, 13385 Marseille cedex 05, France; (N.P.); (P.V.); (A.C.); (C.K.); (P.R.)
- Author to whom correspondence should be addressed; ; Tel.: +33-491-835-580; Fax: +33-491-794-677
| |
Collapse
|
38
|
Voisin-Chiret AS, Burzicki G, Perato S, De Giorgi M, Franchini C, Sopková-de Oliveira Santos J, Rault S. Aromatic garlands, as new foldamers, to mimic protein secondary structure. Tetrahedron 2012. [DOI: 10.1016/j.tet.2012.02.035] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
39
|
Dulin F, Halm-Lemeille MP, Lozano S, Lepailleur A, Sopkova-de Oliveira Santos J, Rault S, Bureau R. Interpretation of honeybees contact toxicity associated to acetylcholinesterase inhibitors. Ecotoxicol Environ Saf 2012; 79:13-21. [PMID: 22321412 DOI: 10.1016/j.ecoenv.2012.01.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2011] [Revised: 01/06/2012] [Accepted: 01/08/2012] [Indexed: 05/31/2023]
Abstract
The widespread use of different pesticides generates adverse effects on non target organisms like honeybees. Organophosphorous and carbamates kill honeybees through the inactivation of acetylcholinesterase (AChE), thereby interfering with nerve signaling and function. For this class of pesticides, it is fundamental to understand the relationship between their structures and the contact toxicity for honeybees. A Quantitative Structure-Activity Relationship (QSAR) study was carried out on 45 derivatives by a genetic algorithm approach starting from more than 2500 descriptors. In parallel, a new 3D model of AChE associated to honeybees was defined. Physicochemical properties of the receptor and docking studies of the derivatives allow understanding the meaningful of three descriptors and the implication of several amino acids in the overall toxicity of the pesticides.
Collapse
Affiliation(s)
- Fabienne Dulin
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-4258, INC3M FR CNRS 3038, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Boulevard Becquerel, 14032 Caen Cedex, France
| | - Marie-Pierre Halm-Lemeille
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-4258, INC3M FR CNRS 3038, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Boulevard Becquerel, 14032 Caen Cedex, France
| | - Sylvain Lozano
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-4258, INC3M FR CNRS 3038, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Boulevard Becquerel, 14032 Caen Cedex, France
| | - Alban Lepailleur
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-4258, INC3M FR CNRS 3038, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Boulevard Becquerel, 14032 Caen Cedex, France
| | - Jana Sopkova-de Oliveira Santos
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-4258, INC3M FR CNRS 3038, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Boulevard Becquerel, 14032 Caen Cedex, France
| | - Sylvain Rault
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-4258, INC3M FR CNRS 3038, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Boulevard Becquerel, 14032 Caen Cedex, France
| | - Ronan Bureau
- Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-4258, INC3M FR CNRS 3038, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Boulevard Becquerel, 14032 Caen Cedex, France.
| |
Collapse
|
40
|
Gautier B, Miteva MA, Goncalves V, Huguenot F, Coric P, Bouaziz S, Seijo B, Gaucher JF, Broutin I, Garbay C, Lesnard A, Rault S, Inguimbert N, Villoutreix BO, Vidal M. Targeting the proangiogenic VEGF-VEGFR protein-protein interface with drug-like compounds by in silico and in vitro screening. ACTA ACUST UNITED AC 2012; 18:1631-9. [PMID: 22195565 DOI: 10.1016/j.chembiol.2011.10.016] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2011] [Revised: 09/16/2011] [Accepted: 10/24/2011] [Indexed: 12/29/2022]
Abstract
Protein-protein interactions play a central role in medicine, and their modulation with small organic compounds remains an enormous challenge. Because it has been noted that the macromolecular complexes modulated to date have a relatively pronounced binding cavity at the interface, we decided to perform screening experiments over the vascular endothelial growth factor receptor (VEGFR), a validated target for antiangiogenic treatments with a very flat interface. We focused the study on the VEGFR-1 D2 domain, and 20 active compounds were identified. These small compounds contained a (3-carboxy-2-ureido)thiophen unit and had IC(50) values in the low micromolar range. The most potent compound inhibited the VEGF-induced VEGFR-1 transduction pathways. Our findings suggest that our best hit may be a promising scaffold to probe this macromolecular complex and for the development of treatments of VEGFR-1-dependent diseases.
Collapse
Affiliation(s)
- Benoit Gautier
- Université Paris Descartes, CNRS UMR 8601, UFR biomédicale, 75006 Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Perato S, Voisin-Chiret AS, Sopková-de Oliveira Santos J, Legay R, Oulyadi H, Rault S. Synthesis of new linear poly(phenylpyridyl) chains. Tetrahedron 2012. [DOI: 10.1016/j.tet.2011.12.074] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
42
|
Sopkova-de Oliveira Santos J, Voisin-Chiret AS, Burzicki G, Sebaoun L, Sebban M, Lohier JF, Legay R, Oulyadi H, Bureau R, Rault S. Structural Characterizations of Oligopyridyl Foldamers, α-Helix Mimetics. J Chem Inf Model 2012; 52:429-39. [DOI: 10.1021/ci200424a] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Jana Sopkova-de Oliveira Santos
- Centre d’Etudes et de
Recherche sur le Médicament de Normandie, UPRES EA-4258, FR
CNRS INC3M, UFR des Sciences Pharmaceutiques, Université de
Caen, bd Becquerel,
14032 Caen Cedex, France
| | - Anne Sophie Voisin-Chiret
- Centre d’Etudes et de
Recherche sur le Médicament de Normandie, UPRES EA-4258, FR
CNRS INC3M, UFR des Sciences Pharmaceutiques, Université de
Caen, bd Becquerel,
14032 Caen Cedex, France
| | - Gregory Burzicki
- Centre d’Etudes et de
Recherche sur le Médicament de Normandie, UPRES EA-4258, FR
CNRS INC3M, UFR des Sciences Pharmaceutiques, Université de
Caen, bd Becquerel,
14032 Caen Cedex, France
| | - Laure Sebaoun
- Centre d’Etudes et de
Recherche sur le Médicament de Normandie, UPRES EA-4258, FR
CNRS INC3M, UFR des Sciences Pharmaceutiques, Université de
Caen, bd Becquerel,
14032 Caen Cedex, France
| | - Muriel Sebban
- Equipe Analyse et Modélisation
Moléculaire, IRCOF UMR6014 CNRS-COBRA, Université de
Rouen, rue Tesnière, 76821 Mont-Saint-Aignan, France
| | - Jean-François Lohier
- Laboratoire de Chimie Moléculaire
et Thio-organique, UMR CNRS 6507, FR CNRS 3038 INC3M, ENSICAEN - Université
de Caen, 14050 Caen, France
| | - Rémi Legay
- Centre d’Etudes et de
Recherche sur le Médicament de Normandie, UPRES EA-4258, FR
CNRS INC3M, UFR des Sciences Pharmaceutiques, Université de
Caen, bd Becquerel,
14032 Caen Cedex, France
| | - Hassan Oulyadi
- Equipe Analyse et Modélisation
Moléculaire, IRCOF UMR6014 CNRS-COBRA, Université de
Rouen, rue Tesnière, 76821 Mont-Saint-Aignan, France
| | - Ronan Bureau
- Centre d’Etudes et de
Recherche sur le Médicament de Normandie, UPRES EA-4258, FR
CNRS INC3M, UFR des Sciences Pharmaceutiques, Université de
Caen, bd Becquerel,
14032 Caen Cedex, France
| | - Sylvain Rault
- Centre d’Etudes et de
Recherche sur le Médicament de Normandie, UPRES EA-4258, FR
CNRS INC3M, UFR des Sciences Pharmaceutiques, Université de
Caen, bd Becquerel,
14032 Caen Cedex, France
| |
Collapse
|
43
|
Verhaeghe P, Dumètre A, Castera-Ducros C, Hutter S, Laget M, Fersing C, Prieri M, Yzombard J, Sifredi F, Rault S, Rathelot P, Vanelle P, Azas N. 4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum. Bioorg Med Chem Lett 2011; 21:6003-6. [DOI: 10.1016/j.bmcl.2011.06.113] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2011] [Revised: 06/25/2011] [Accepted: 06/26/2011] [Indexed: 11/15/2022]
|
44
|
Caruso A, Chimento A, El-Kashef H, Lancelot JC, Panno A, Pezzi V, Saturnino C, Sinicropi MS, Sirianni R, Rault S. Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part I. J Enzyme Inhib Med Chem 2011; 27:609-13. [DOI: 10.3109/14756366.2011.603132] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Anna Caruso
- Department of Pharmaceutical Sciences, University of Calabria,
Arcavacata di Rende (CS), Italy
| | - Adele Chimento
- Department of Pharmaco-Biology, University of Calabria,
Arcavacata di Rende (CS), Italy
| | - Hussein El-Kashef
- Chemistry Department, Faculty of Science, Assiut University,
Assiut, Egypt
| | - Jean-Charles Lancelot
- Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Centre d’Etudes et de Recherche sur le Médicament de Normandie, Boulevard Becquerel,
Caen Cedex, France
| | - Antonella Panno
- Department of Pharmaceutical Sciences, University of Calabria,
Arcavacata di Rende (CS), Italy
| | - Vincenzo Pezzi
- Department of Pharmaco-Biology, University of Calabria,
Arcavacata di Rende (CS), Italy
| | - Carmela Saturnino
- Department of Pharmaceutical and Biomedical Sciences, University of Salerno,
Fisciano (SA), Italy
| | | | - Rosa Sirianni
- Department of Pharmaco-Biology, University of Calabria,
Arcavacata di Rende (CS), Italy
| | - Sylvain Rault
- Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, Centre d’Etudes et de Recherche sur le Médicament de Normandie, Boulevard Becquerel,
Caen Cedex, France
| |
Collapse
|
45
|
Castera-Ducros C, Azas N, Verhaeghe P, Hutter S, Garrigue P, Dumètre A, Mbatchi L, Laget M, Remusat V, Sifredi F, Rault S, Rathelot P, Vanelle P. Targeting the human malaria parasite Plasmodium falciparum: In vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series. Eur J Med Chem 2011; 46:4184-91. [DOI: 10.1016/j.ejmech.2011.06.021] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2011] [Revised: 06/11/2011] [Accepted: 06/16/2011] [Indexed: 10/18/2022]
|
46
|
Dubost E, Fossey C, Cailly T, Rault S, Fabis F. Selectiveortho-Bromination of Substituted Benzaldoximes Using Pd-Catalyzed C–H Activation: Application to the Synthesis of Substituted 2-Bromobenzaldehydes. J Org Chem 2011; 76:6414-20. [DOI: 10.1021/jo200853j] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
47
|
Rochais C, Yougnia R, Cailly T, Sopková-de Oliveira Santos J, Rault S, Dallemagne P. One-pot synthesis of new aza- and diaza-aminophenanthrenes. Tetrahedron 2011. [DOI: 10.1016/j.tet.2011.05.116] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
48
|
De Giorgi M, Voisin-Chiret AS, Sopková-de Oliveira Santos J, Corbo F, Franchini C, Rault S. Design and synthesis of thienylpyridyl garlands as non-peptidic alpha helix mimetics and potential protein–protein interactions disruptors. Tetrahedron 2011. [DOI: 10.1016/j.tet.2011.06.074] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
49
|
|
50
|
Lecoutey C, Fossey C, Rault S, Fabis F. Efficient Room-Temperature One-Pot Synthesis of 2-Amino-3-alkyl(3-aryl)quinazolin-4(3H)-ones. European J Org Chem 2011. [DOI: 10.1002/ejoc.201100200] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|